DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Ryan CJ, Smith MR, Fizazi K. et al.
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Lancet Oncol 2015;
16: 152-160
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.